Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

18.99 -0.16 (-0.84%)
Streaming Delayed Price Updated: 1:29 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 335,785
Open 19.00
Bid (Size) 18.99 (100)
Ask (Size) 19.02 (700)
Prev. Close 19.15
Today's Range 18.79 - 19.34
52wk Range 13.50 - 30.81
Shares Outstanding 48,333,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and... 
Via StockStory
Topics Stocks
News headline image
STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?
STAAR Surgical’s 23.7% return over the past six months has outpaced the S&P 500 by 13.1%, and its stock price has climbed to $21.14 per share. This was partly due to its solid quarterly results, and... 
Via StockStory
Topics Stocks

Performance

YTD
-19.5%
-19.5%
1 Month
-18.8%
-18.8%
3 Month
-28.6%
-28.6%
6 Month
+4.9%
+4.9%
1 Year
-24.0%
-24.0%

More News

Read More
News headline image
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
From STAAR Surgical Company
Via Business Wire
News headline image
3 Stocks Under $50 That Fall Short
Via StockStory
Topics Economy
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
News headline image
New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Low-Volatility Stocks We Keep Off Our Radar
Via StockStory
News headline image
What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Cash-Heavy Stocks We Keep Off Our Radar
Via StockStory
News headline image
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
From Broadwood Partners, L.P.
Via Business Wire
News headline image
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
From STAAR Surgical Company
Via Business Wire
News headline image
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
From Yunqi Capital Limited
Via Business Wire
News headline image
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
Why STAAR Surgical (STAA) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence
News headline image
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
1 Russell 2000 Stock Worth Investigating and 2 We Find Risky
Via StockStory
News headline image
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
From Yunqi Capital Limited
Via Business Wire

Frequently Asked Questions

Is STAAR Surgical Company - Common Stock publicly traded?
Yes, STAAR Surgical Company - Common Stock is publicly traded.
What exchange does STAAR Surgical Company - Common Stock trade on?
STAAR Surgical Company - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for STAAR Surgical Company - Common Stock?
The ticker symbol for STAAR Surgical Company - Common Stock is STAA on the Nasdaq Stock Market
What is the current price of STAAR Surgical Company - Common Stock?
The current price of STAAR Surgical Company - Common Stock is 18.99
When was STAAR Surgical Company - Common Stock last traded?
The last trade of STAAR Surgical Company - Common Stock was at 01/29/26 01:29 PM ET
What is the market capitalization of STAAR Surgical Company - Common Stock?
The market capitalization of STAAR Surgical Company - Common Stock is 917.85M
How many shares of STAAR Surgical Company - Common Stock are outstanding?
STAAR Surgical Company - Common Stock has 918M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.